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Vaginal Cleansing Before Cesarean Delivery
A Systematic Review and Meta-analysis
Claudia Caissutti, MD, Gabriele Saccone, MD, Fabrizio Zullo, MD, Johanna Quist-Nelson, MD,
Laura Felder, MD, Andrea Ciardulli, MD, and Vincenzo Berghella, MD
OBJECTIVE: To assess the efficacy of vaginal cleansing
before cesarean delivery in reducing postoperative
endometritis.
DATA SOURCES: MEDLINE, Ovid, EMBASE, Scopus,
Clinicaltrials.gov, and Cochrane Library were searched
from their inception to January 2017.
METHODS OF STUDY SELECTION: Selection criteria
included all randomized controlled trials comparing
vaginal cleansing (ie, intervention group) with a control
group (ie, either placebo or no intervention) in women
undergoing cesarean delivery. Any method of vaginal
cleansing with any type of antiseptic solution was
included. The primary outcome was the incidence of
endometritis. Meta-analysis was performed using the
random-effects model of DerSimonian and Laird to
produce summary treatment effects in terms of relative
risk (RR) with 95% CI.
TABULATION, INTEGRATION, AND RESULTS: Sixteen
trials (4,837 women) on vaginal cleansing immediately
before cesarean delivery were identified as relevant and
included in the review. In most of the included studies,
10% povidone–iodine was used as an intervention. The
most common way to perform the vaginal cleansing was
the use of a sponge stick for approximately 30 seconds.
Women who received vaginal cleansing before cesarean
delivery had a significantly lower incidence of endome-
tritis (4.5% compared with 8.8%; RR 0.52, 95% CI 0.37–
0.72; 15 studies, 4,726 participants) and of postoperative
fever (9.4% compared with 14.9%; RR 0.65, 95% CI 0.50–
0.86; 11 studies, 4,098 participants) compared with the
control group. In the planned subgroup analyses, the
reduction in the incidence of endometritis with vaginal
cleansing was limited to women in labor before cesarean
delivery (8.1% compared with 13.8%; RR 0.52, 95% CI
0.28–0.97; four studies, 440 participants) or those with
ruptured membranes (4.3% compared with 20.1%; RR
0.23, 95% CI 0.10–0.52; three studies, 272 participants).
CONCLUSION: Vaginal cleansing immediately before
cesarean delivery in women in labor and in women with
ruptured membranes reduces the risk of postoperative
endometritis. Because it is generally inexpensive and
a simple intervention, we recommend preoperative
vaginal preparation before cesarean delivery in these
women with sponge stick preparation of povidone–
iodine 10% for at least 30 seconds. More data are
needed to assess whether this intervention may be also
useful for cesarean deliveries performed in women not in
labor and for those without ruptured membranes.
SYSTEMATIC REVIEW REGISTRATION: PROSPERO
International prospective register of systematic reviews,
https://www.crd.york.ac.uk/PROSPERO/, CRD42017054843.
(Obstet Gynecol 2017;130:527–38)
DOI: 10.1097/AOG.0000000000002167
The most important risk factor for postpartummaternal infection is cesarean delivery.1 Women
undergoing cesarean delivery have a 5- to 20-fold
greater risk for infection and infectious morbidity
compared with those undergoing a vaginal birth.1
Postcesarean delivery infection is a major health
problem, which can cause maternal morbidity and
mortality. The most frequent postcesarean infective
complications are endometritis (6–27%), clinically sig-
nificant fever (5–24%), and wound infection (2–9%).2
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Postpartum endometritis occurs after 1–3% of all
deliveries and it is up to 10 times more common after
cesarean delivery.1,2
The main cause of endometritis is ascending
infection by mostly anaerobic bacteria from the vagina.3
Compared with placebo or no treatment, presurgical
broad-spectrum antibiotic prophylaxis administration
in women undergoing cesarean delivery reduced the
incidence of infectious complications by 60–70%.4,5 It
is unclear whether additional benefit could be obtained
by cleansing the vagina with antibacterial agents. In the
last few years several randomized controlled trials
(RCTs) have investigated the efficacy of vaginal cleans-
ing with antiseptic solutions before cesarean delivery.6
In a Cochrane review, Haas et al6 pooled data from five
RCTs evaluating the effects of vaginal cleansing with
povidone–iodine on postcesarean infectious morbidity.
They showed with a low quality of evidence that vagi-
nal preparation with povidone–iodine immediately
before cesarean delivery may reduce the risk of post-
operative endometritis.
The aim of this review was to assess the efficacy of
vaginal cleansing before cesarean delivery in reducing
postoperative endometritis through a systematic
review of RCTs and a meta-analysis.
SOURCES
This review was performed according to a protocol
recommended for systematic review.7 The review
protocol was designed a priori to define methods for
collecting, extracting, and analyzing data. The
research was conducted with the use of MEDLINE,
Ovid, EMBASE, Scopus, Clinicaltrials.gov, and Co-
chrane Library as electronic databases by two inde-
pendent reviewers (C.C., L.F.). The trials were
identified with the use of a combination of the follow-
ing text words: “vaginal irrigation,” “cesarean,” “preg-
nancy,” “infection,” “caesarean,” “endometritis,”
“povidone-iodine,” “chlorhexidine,” “trial,” and “ran-
domized” from the inception of each database to Jan-
uary 2017. Review of articles also included the
abstracts of all references that were retrieved from
the search. No restrictions for language or geographic
location were applied.
STUDY SELECTION
Selection criteria included all RCTs comparing vag-
inal cleansing (ie, intervention group) with a control
group (ie, either placebo or no intervention) in
women undergoing cesarean delivery. Trials in
women undergoing vaginal delivery were excluded
as were trials not reporting any of our outcomes of
interest.8 Any method of vaginal cleansing (eg,
douches, wipes, sponges) with any type of antiseptic
solution (eg, povidone–iodine, chlorhexidine) was
included. Trials comparing different solutions were
also included but analyzed separately.
Only trials in which vaginal preparation was
performed no more than 1 hour before surgery were
included. This review addressed the use of preoper-
ative vaginal cleansing after the decision to perform
cesarean delivery had been made and did not address
the use of vaginal preparation during labor.
The risk of bias in each included study was
assessed by using the criteria outlined in the Cochrane
Handbook for Systematic Reviews of Interventions. Seven
domains related to risk of bias were assessed in each
Fig. 1. Flow diagram of studies identified in the systematic
review. *One study was analyzed separately.
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included trial because there is evidence that these
issues are associated with biased estimates of treat-
ment effect: 1) random sequence generation, 2) allo-
cation concealment, 3) blinding of participants and
personnel, 4) blinding of outcome assessment, 5)
incomplete outcome data, 6) selective reporting,
and 7) other bias. Review authors’ judgments were
categorized as “low risk,” “high risk,” or “unclear
risk” of bias.7
For each trial, data regarding vaginal cleansing
procedure and incidence of infective complications
were extracted and carefully reviewed. We planned to
review the type of solution used and duration of the
procedure.
The primary outcome was the incidence of
endometritis as defined by the original trials. Second-
ary outcomes were postoperative wound infection;
postoperative fever greater than 38°C or 100.4°F; and
other wound complications including postoperative
wound seroma or hematoma.
For the primary outcome, the following subgroup
analyses were planned:
1. Women in labor compared with those not in
labor;
2. Women with ruptured membranes compared
with those with intact membranes;
3. Type of antiseptic solution; and
4. Time of use of prophylactic antibiotics.
We also excluded studies in which prophylactic
surgical antibiotics were explicitly not used. Surgical
prophylaxis with intravenous antibiotics before or
during cesarean deliveries has been clearly demon-
strated as beneficial in reducing postoperative infec-
tious morbidities. Thus, it is the standard of care.
Inclusion of trials not using general surgical antibiotic
prophylaxis would not represent the current standard
of care and the results would not be translatable into
current practice.
The data analysis was completed independently
by two authors (A.C., G.S.) using Review Manager
Fig. 2. Assessment of risk of bias. A. Summary of risk of bias for each trial. Plus sign indicates low risk of bias, minus sign
indicates high risk of bias, and question mark indicates unclear risk of bias. B. Risk of bias items presented as percentages
across all included studies.
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Table 1. Characteristics of the Included Trials
Author, Year Country
Sample Size
(Intervention vs
control) Inclusion Criteria
Rouse, 199710 United States 130 (62 vs 68)* Patients admitted for delivery at 24 wk of
gestation or greater
Sweeten, 19972 United States 64 (32 vs 32)* Patient in labor with intact membranes at 36 wk
of gestation or greater
Pitt, 200111 United States 224 (112 vs 112) Patients 24 wk of gestation or greater undergoing
cesarean delivery, no intrapartum infections
Reid, 200112 United States 430 (217 vs 213) Patients undergoing cesarean delivery
Guzman, 200213 United States 160 (80 vs 80) Patients undergoing planned cesarean delivery
Starr, 200514 United States 308 (142 vs 166) Patients undergoing nonemergent planned
cesarean delivery
Haas, 201015 United States 300 (155 vs 145) Patients undergoing cesarean delivery
Asghani, 201116 Iran 568 (284 vs 284) Patients undergoing cesarean delivery
Memon, 201117 Pakistan 200 (100 vs 100) Patients undergoing cesarean delivery
Charoenviboonphan, 201118 Thailand 599 (299 vs 300) Patients undergoing cesarean delivery
Yildirim, 201219 Turkey 669 (334 vs 335) Patients undergoing cesarean delivery at 39 wk
of gestation or greater
Mohamed, 201521 Egypt 200 (100 vs 100) Patient undergoing nonemergent planned
cesarean delivery at 39 wk of gestation or
greater
Nandi, 201522 Bangladesh 274 (136 vs 138) Patients undergoing cesarean delivery
Tewfik, 201523 Egypt 93 (46 vs 47) Patient undergoing nonemergent planned
cesarean delivery at 39 wk of gestation or
greater
Ahmed, 201624 Egypt 218 (109 vs 109) Singletons undergoing nonemergent planned
cesarean delivery at 39 wk of gestation or
greater
Barat, 201625 Iran 400 (200 vs 200) Singletons undergoing nonemergent planned
cesarean delivery at 39 wk of gestation or
greater
DM, diabetes mellitus; BMI, body mass index; ROM, rupture of membranes at the time of randomization; PROM, prelabor rupture of
membranes.
Data are total number (number in the intervention group vs number in the control group).
* We considered only women who underwent cesarean delivery.
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Exclusion Criteria
Intervention Group (Vaginal
Cleansing)
Control Group Primary Outcome(s)
Contraindication to digital cervical examination,
active genital herpes, chorioamnionitis before
randomization, or known or suspected allergy
to chlorhexidine
225 mL chlorhexidine diacetate 0.2% Placebo (sterile
water)
Intrapartum
chorioamnionitis,
postpartum
endometritis
Contraindication to digital cervical examination,
active genital herpes, chorioamnionitis before
randomization, malpresentation, or known or
suspected allergy to chlorhexidine
20 mL chlorhexidine diacetate 0.4% Placebo (sterile
water)
Intraamniotic infection
Patients with chorioamnionitis or suspected
allergy to metronidazole
Metronidazole 0.5% 5 g vaginal gel
(37.5 mg)
Placebo (5 g vaginal
gel)
Postcesarean endometritis
Highly emergent cesarean delivery, allergy to
povidone–iodine, iodine, or shellfish; bleed-
ing placenta previa; and active genital herpes
Sponge stick preparation of
povidone–iodine 10%
No treatment Fever, endometritis
Emergent need for delivery, allergy, or placenta
previa
Sponge stick preparation of povidone–
iodine in vagina for 3 min
Placebo (sponge stick
preparation of
saline in vagina for
3 min)
Postcesarean endometritis
Placenta previa, diagnosis of chorioamnionitis Sponge stick preparation of povidone–
iodine in vagina for 30 s
No treatment Postoperative febrile
morbidity,
endometritis, wound
infection
Allergy to iodine-containing solutions or
planned cesarean hysterectomy
Sponge stick preparation of
povidone–iodine 1% in vagina
No treatment Postoperative fever,
endometritis, early
wound complications
Povidone–iodine hypersensitivity; active cho-
rioamnionitis; gestational herpes; abnormal
vaginal discharge during pregnancy (foul-smell-
ing discharge with pruritus, which could stain
underwear); emergency cesarean delivery
Sponge stick preparation of
povidone–iodine 10% in vagina for
30 s
No treatment Febrile morbidity,
endometritis, wound
infection
Allergy to iodine-containing solutions and
bleeding placenta previa
Sponge stick preparation of
povidone–iodine 10% in vagina
No treatment Febrile morbidity,
endometritis, wound
infection
Allergy to iodine-containing solutions and
bleeding placenta previa
Sponge stick preparation of
povidone–iodine 1% in vagina
No treatment Postoperative fever,
endometritis, wound
infection, length of
hospital stay
Umbilical cord prolapse, placenta previa,
allergy to povidone–iodine
Sponge stick preparation of povidone–
iodine in vagina for 30 s
No treatment Postoperative fever,
endometritis, wound
infection
DM, anemia, history of postcesarean delivery
infection, obstructed labor, preeclampsia,
allergy to Cetrimide
Vaginal preparation with diluted
Cetrimide 50 cc
No treatment Postpartum morbidity
Cesarean delivery with deeply engaged head,
bleeding placenta previa, active genital
herpes, and allergy to iodine
Vaginal scrub with povidone–iodine
5%
No treatment Endometritis, abdominal
wound infection
BMI greater than 30 kg/m2, ROM, antepartum
hemorrhage, chronic steroid or
immunosuppressive treatment
Vaginal preparation with povidone–
iodine
Vaginal preparation
with chlorhexidine
Postoperative fever and
endometritis
PROM, placenta previa, immunocompromised
status
Vaginal cleansing with sterile gauze
pieces 225 mL chlorhexidine
diacetate 0.2% for approximately
1 min
Placebo (sterile
water)
Adverse postcesarean
infectious morbidities
Allergy to povidone–iodine, antepartum hemor-
rhage, ROM diabetes
Sponge stick preparation of povidone–
iodine 10% in vagina for 30 s
No treatment Postoperative fever,
postpartum endometritis,
early wound
complications
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5.3. The completed analyses were then compared, and
any difference was resolved by discussion with a third
reviewer (V.B.). Data from each eligible study were
extracted without modification of original data onto
custom-made data collection forms. For continuous
outcomes, means6SDs were extracted and imported
into Review Manager 5.3. Meta-analysis was per-
formed using the random-effects model of DerSimo-
nian and Laird to produce summary treatment effects
in terms of mean difference or relative risk (RR) with
Table 2. Technical Characteristics of Cesarean Delivery
Author, Year Time of Cesarean Delivery Patients in Labor (n)
Patients With ROM at
Randomization (n)
Rouse, 199710 Planned, after labor or emergent 56/62 vs 60/68 Not stated
Sweeten, 19972 After labor or emergent 32/32 vs 32/32 0/32 vs 0/32
Pitt, 200111 Planned, after labor or emergent 64/112 vs 67/112 10/112 vs 16/112
Reid, 200112 Planned, or after labor 107/217 vs 104/213 Not stated
Guzman, 200213 Planned None 36/80 vs 36/80
Starr, 200514 Planned None 86/142 vs 113/166
Haas, 201015 Planned, after labor or emergent 45/155 vs 50/145 34/155 vs 42/145
Asghania, 201116 Planned, after labor or emergent Not stated Not stated
Memon, 201117 Planned, after labor or emergent 31/100 vs 38/100 25/100 vs 33/100
Charoenviboonphan, 201118 Planned, after labor or emergent Not stated Not stated
Yildirim, 201219 Planned, after labor or emergent 115/334 vs 97/335 68/334 vs 56/335
Mohamed, 201521 Planned None 5/100 vs 4/100
Nandi, 201522 Planned, after labor or emergent 92/136 vs 94/138 16/136 and 18/138
Tewfik, 201523 Planned None None
Ahmed, 201624 Planned None None
Barat, 201625 Planned None None
ROM, rupture of membranes; bpm, beats per minute.
Data are number in the intervention group vs number in the control group.
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95% CI. Heterogeneity was measured using Higgins
I2. Potential publication biases were assessed statisti-
cally by using Begg’s and Egger’s tests. The meta-
analysis was reported following the Preferred
Reporting Item for Systematic Reviews and Meta-
analyses statement.9 Before data extraction, the
review was registered with the PROSPERO Interna-
tional Prospective Register of Systematic Reviews
(Registration Number: CRD42017054843).
RESULTS
Seventeen RCTs2,10–25 were identified as relevant and
met the inclusion criteria (Fig. 1). However, Ameer
et al20 was excluded because it was an unauthorized
Chorioamnionitis
(n) Timing of Antibiotics Definition of Endometritis
Not stated All patients after cord clamping Temperature greater than 100.4˚F, a diagnosis of endometritis by
the managing physicians, one or more symptoms or signs:
uterine tenderness, maternal tachycardia (greater than 100 bpm),
purulent or foul-smelling cervical discharge, or maternal
leukocytosis (greater than 12,000 cells/mL3)
Not stated All patients after cord clamping Temperature greater than 100˚F with two of the following criteria:
maternal tachycardia, uterine tenderness, foul-smelling amniotic
fluid, maternal leukocytosis, or fetal tachycardia.
Not stated 89/112 vs 95/112 (after cord clamping)
and 23/112 vs 17/112 (before incision)
Oral temperature 38˚C or greater on any 2 postoperative
d (excluding the first 24 h) and one or more sign: uterine
tenderness to palpation, maternal tachycardia (at least 100 bpm),
foul-smelling vaginal discharge, or maternal leukocytosis
(greater than 12,000/mm3)
68/500 322/430 (after cord clamping) and 172/
430 (antepartum)
Postoperative fever with a physician’s note indicating uterine or
abdominal pain or tenderness, preceding an order for broad-
spectrum, intravenous antibiotics, without other apparent source
of serious infection
Not stated Not stated Temperature greater than 100.4˚F at least twice, 24 h after surgery,
or of greater than 101˚F at any time after surgery, with abdominal
or uterine tenderness
Not stated All patients after cord clamping Temperature greater than 38.4˚C persisting beyond the first
postoperative d, with uterine tenderness and foul lochia, in the
absence of physical or laboratory evidence of other infection
5/155 vs 9/145 All patients after cord clamping Uterine tenderness plus postoperative fever requiring antibiotic
administration
Not stated All patients before incision Temperature greater than 38.4˚C persisting beyond the first
postoperative d, in association with uterine tenderness and foul
lochia, in the absence of physical or laboratory evidence of other
infection
4/100 vs 6/100 All patients before incision Postoperative fever greater than 38.4˚C with uterine tenderness
and foul-smelling lochia requiring broad-spectrum intravenous
antibiotic administration
Not stated Not stated Postoperative fever greater than 38.4˚C with uterine tenderness
and foul-smelling lochia requiring broad-spectrum intravenous
antibiotic administration
Not stated All patients before incision Body temperature greater than 38.5˚C with concomitant foul-
smelling discharge or abnormally tender uterus on bimanual
examination
Not stated All patients before incision and
postoperatively
Presence of fever, purulent lochia and fundal tenderness, needed
antibiotic therapy
Not stated All patients after cord clamping Uterine tenderness plus postoperative fever with leucocytosis
Not stated All patients before incision and
postoperatively
Fever 38˚C, uterine tenderness, and offensive vaginal discharge
that necessitate antibiotic treatment
Not stated All patients before incision Postoperative fever greater than 38.4˚C at least twice 24 h after
delivery associated with uterine tenderness and persistent
offensive lochia
Not stated All patients after cord clamping and
postoperatively
Fever greater than 38˚C with uterine tenderness and foul-smelling
lochia, which require a wide variety of intravenous antibiotics
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duplication of Starr et al.14 Therefore, 16 RCTs
(n54,837 women)10–19,21–25 were included in the sys-
tematic review, of which 15 RCTs,10–22,24,25 involving
4,744 women randomized to either vaginal cleansing
before cesarean delivery or control (ie, either placebo
or no treatment), contributed data to the quantitative
meta-analysis. One trial23 compared vaginal prepara-
tion with povidone–iodine with vaginal preparation
with chlorhexidine and therefore was analyzed sepa-
rately. Publication bias, assessed statistically by using
Begg’s and Egger’s tests, showed no significant bias
(P5.33 and P5.27, respectively).
The overall risk of bias was low. Most of the
included studies had a low risk of bias in “random
sequence generation.” In three trials, the method of
random sequence generation was judged as inade-
quate. Adequate methods for allocation of women
were used in all the included trials, but one in which
details on methods used to conceal allocation were
not reported and in three that were judged as inade-
quate. Regarding “incomplete outcome data,” 14
RCTs were judged as “low risk” of bias, one as
“unclear,” and one as “high risk” of bias (Fig. 2).
The studies came from different countries, including
both high-income and low- and middle-income coun-
tries. Seven trials originated from the United States.
The year of the trials’ publication ranged from 1997 to
2016, and most of them were published after 2010.
Six trials included only women undergoing planned,
scheduled, nonemergent cesarean delivery, and nine
included also laboring women or emergent cesarean
delivery, whereas Sweeten et al2 included only labor-
ing women (Table 1). Of the nine studies that included
also laboring women, two RCTs did not state the
number of included laboring women, whereas seven
RCTs included overall 1,020 of 2,227 laboring
women (510/1,116 and 510/1,111 in the intervention
and the control groups, respectively) (Table 2). Four
trials explicitly included only women at 39 weeks of
gestation or greater (Table 1).
In most of the included studies (11 RCTs),
povidone–iodine was used as an intervention. Of
them, four did not report the percentage of the solu-
tion, four used 10% povidone–iodine, two used 1%,
and one used 5%. Two trials used 225 mL chlorhex-
idine diacetate 0.2%, one used 20 mL chlorhexidine
diacetate 0.4%, and one trial used metronidazole 0.5%
5 g vaginal gel; the other trial used Cetrimide 50 cc. In
five double-blind RCTs,2,10,11,13,24 which used pla-
cebo as a control, neither the participants nor the in-
vestigators were aware of the treatment assignment.
Ten trials used no treatment as control. Tewfik
et al23 compared povidone–iodine (intervention
group) with chlorhexidine (control group) (Table 1).
The most common way to perform the vaginal
cleansing was the use of a sponge stick (nine RCTs) for
approximately 30 seconds (four RCTs). In one trial, the
sponge stick was used for 3 minutes and in one for 60
seconds. One study used vaginal gel, one used vaginal
scrubs, one used sterile gauze, and three did not specify
these details. Sweeten et al2 used a syringe to perform
vaginal cleansing.
All trials used prophylactic or intraoperative
surgical antibiotics. Six studies used antibiotics before
incision, six after cord clamping, two trials either
before incision or after cord clamping, and the other
two did not report timing of antibiotics. In three
studies, antibiotics were administrated also
Fig. 3. Forest plot for the risk of endometritis. M-H, Mantel-Haenszel; df, degrees of freedom.
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postoperatively (Table 2). Data on placental removal
and on peritoneal closure were not available in any of
the trials.
Fifteen RCTs, involving 4,744 women and com-
paring vaginal cleansing with either placebo or no
treatment, were included in the quantitative meta-
analysis. Women who received vaginal cleansing
before cesarean delivery had a significantly lower
incidence of endometritis (4.5% compared with 8.8%;
RR 0.52, 95% CI 0.37–0.72; Fig. 3) and postoperative
fever (9.4% compared with 14.9%; RR 0.65, 95% CI
0.50–0.86) compared with the control group. No sta-
tistically significant differences were found in the inci-
dence of postoperative wound infection or other
wound complications (Table 3). Side effects such as
allergy were not recorded in the included trials.
Three trials stratified data for women in labor
compared with not in labor,15,17,19 and one included
only laboring women.2 There was a statistically signif-
icant reduction in the incidence of endometritis for
women in labor before cesarean delivery who
received vaginal cleansing (8.1% compared with
13.8%; RR 0.52, 95% CI 0.28–0.97; four studies,
440 participants). The subgroup analysis for women
who were not in labor before the operation did not
show a statistically significant benefit in the primary
outcome (3.5% compared with 6.6%; RR 0.62, 95%
CI 0.34–1.15; three studies, 793 participants).
Three trials stratified data for women with rup-
tured membranes compared with women without
ruptured membranes.13,15,19 One trial explicitly
included only women with intact membranes at the
time of randomization.2 There was a statistically sig-
nificant reduction in the rate of endometritis for
women receiving vaginal cleansing with ruptured
membranes (4.3% compared with 20.1%; RR 0.23,
95% CI 0.10–0.52; three studies, 272 participants).
For women with intact membranes at the time of
Table 3. Primary and Secondary Outcomes Comparing Vaginal Cleansing With No Vaginal Cleansing
Author, Year Endometritis Postoperative Fever Wound Infection
Others Wound
Complications*
Rouse, 199710 11/62 (17.7) vs 16/68 (23.5) Not reported Not reported 1/62 (1.6) vs 2/68 (2.9)
Sweeten, 19972 7/32 (21.9) vs 6/32 (18.8) Not reported Not reported Not reported
Pitt, 200111 8/112 (7.1) vs 19/112 (17.0) 15/112 (13.4) vs 21/112
(18.8)
5/112 (4.5) vs 3/112
(2.7)
Not reported
Reid, 200112 19/217 (8.8) vs 16/213 (7.5) 12/217 (5.5) vs 13/213 (6.1) Not reported 12/217 (5.5) vs 18/213 (8.5)
Guzman, 200213 2/80 (2.5) vs 13/80 (16.3) Not reported Not reported 7/80 (8.8) vs 4/80 (5.0)
Starr, 200514 10/142 (7.0) vs 24/166
(14.5)
34/142 (23.9) vs 47/166
(28.3)
1/142 (0.7) vs 2/166
(1.2)
Not reported
Haas, 201015 0/155 (0.0) vs 4/145 (2.8) 2/155 (1.3) vs 7/145 (4.8) 7/155 (4.5) vs 10/145
(6.9)
6/155 (3.9) vs 12/145 (8.3)
Asghania, 201116 1/284 (0.3) vs 7/284 (2.5) 14/284 (4.9) vs 17/284 (6.0) 10/284 (3.5) vs 9/284
(3.2)
Not reported
Memon, 201117 1/100 (1.0) vs 7/100 (7.0) 4/100 (4.0) vs 6/100 (6.0) 1/100 (1.0) vs 3/100
(3.0)
Not reported
Charoenviboonphan,
201118
0/299 (0.0) vs 8/300 (2.7) 34/299 (11.4) vs 93/300
(31.0)
1/299 (0.3) vs 4/300
(1.3)
Not reported
Yildirim, 201219 23/334 (6.9) vs 39/335
(11.6)
55/334 (16.5) vs 61/335
(18.2)
6/334 (1.8) vs 9/335
(2.7)
Not reported
Mohamed, 201521 6/100 (6.0) vs 16/100 (16.0) 10/100 (10.0) vs 23/100
(23.0)
5/100 (5.0) vs 9/100
(9.0)
Not reported
Nandi, 201522 3/136 (2.2) vs 5/138 (3.6) Not reported 4/136 (2.9) vs 7/138
(5.1)
Not reported
Tewfik, 201523,† Not reported Not reported Not reported Not reported
Ahmed, 201624 3/102 (2.9) vs 13/98 (13.3) 2/102 (2.0) vs 4/98 (4.1) 4/102 (3.9) vs 7/98 (7.1) Not reported
Barat, 201625 11/200 (5.5) vs 15/200 (7.5) 10/200 (5.0) vs 14/200 (7.0) 12/200 (6.0) vs 13/200
(6.5)
Not reported
Total 105/2,355 (4.5) vs 208/
2,371 (8.8)
192/2,041 (9.4) vs 306/
2,057 (14.9)
56/1,964 (2.9) vs 76/
1,978 (3.8)
26/514 (5.1) vs 36/506 (7.1)
RR (95% CI) 0.52 (0.37–0.72) 0.65 (0.50–0.86) 0.74 (0.53–1.05) 0.71 (0.43–1.17)
I2 (%) 39 49 0 1
RR, relative risk.
Data are as number in the intervention group (%) vs number in the control group (%) unless otherwise specified.
Bold indicates statistically significant data.
* Other wound complications: seroma, hematoma, wound separation, cellulitis.
† Excluded from the main analysis.
VOL. 130, NO. 3, SEPTEMBER 2017 Caissutti et al Vaginal Preparation Before Cesarean Delivery 535
Copyright ª by The American College of Obstetricians
and Gynecologists. Published by Wolters Kluwer Health, Inc.
Unauthorized reproduction of this article is prohibited.
cesarean delivery, the rate of postoperative endome-
tritis was not significantly reduced in the vaginal prep-
aration group (4.4% compared with 6.8%; RR 0.71,
95% CI 0.40–1.24; three studies, 857 participants).
The subgroup analysis of the 10 trials that used
povidone–iodine as the intervention compared with
placebo or no treatment concurred with the overall
analysis in the significant decrease of endometritis
(2.8% compared with 6.3%; RR 0.42, 95% CI 0.25–
0.71); no differences were found in the subgroup
analysis of the three trials that used chlorhexidine as
the intervention compared with placebo or no treat-
ment (8.5% compared with 17.5%; RR 0.45, 95% CI
0.14–1.52; 330 participants).
The subgroup analysis of the six RCTs in which
all women received antibiotics before incision also
concurred with the overall analysis in the significant
decrease of endometritis (2.0% compared with 6.1%;
RR 0.33, 95% CI 0.17–0.63; six studies, 2,167
participants).
Only one study directly compared povidone–
iodine with chlorhexidine and therefore meta-
analyses for these data were not available.23 However,
they found no statistically significant difference in the
incidence of endometritis comparing vaginal cleans-
ing with povidone–iodine with vaginal cleansing with
chlorhexidine (8.6% compared with 4.3%; RR 2.04,
95% CI 0.39–10.62; 93 participants).
DISCUSSION
This meta-analysis showed that vaginal cleansing
before cesarean delivery reduces the incidence of
postpartum endometritis compared with no such
cleansing. Subgroup analyses demonstrated that the
reduction in postoperative endometritis is significant
only for women in labor and for those with ruptured
membranes. Ruptured membranes are a known risk
factor for postcesarean infectious morbidity and
therefore the use of vaginal preparation in this subset
of women makes particular sense. The risk of bias of
the included trials is reasonably moderate with few
areas being identified as potential sources of bias. In
most of the included studies, 10% povidone–iodine
was used as the intervention. The most common
way to perform the vaginal cleansing was the use of
a sponge stick for approximately 30 seconds. No side
effects such as allergy were reported in any of the
trials.
We also found a 67% decrease in the rate of
endometritis from vaginal cleansing in the subgroup
of women who received prophylactic antibiotics
before skin incision. Surgical prophylaxis with intra-
venous antibiotics before cesarean delivery has been
clearly demonstrated as beneficial in reducing post-
operative infection morbidity.5 Thus, it is the standard
of care and these findings could translate to current
practice.
Limitations of our study are mostly inherent to
the limitations of the included studies. Only four trials
used placebo as a control and were double-blind. Data
regarding optimal dose and optimal type of antiseptic
to use were limited. Although povidone–iodine was
the most commonly used antiseptic, the efficacy of
chlorhexidine, although nonsignificant, was similar
(RR 0.42 for povidone–iodine compared with 0.45 for
chlorhexidine). Moreover, the one RCT comparing
povidone–iodine and chlorhexidine vaginal cleansing
failed to find any statistically significant difference.23
Many of the subset analyses, including comparison of
povidone–iodine and chlorhexidine, had small sam-
ple sizes and may be underpowered to detect statisti-
cally significant differences. Alcohol-containing
preparations have not been studied and should
probably be avoided.
Some published trials comparing vaginal cleans-
ing with either placebo or no treatment were excluded
because they included both vaginal and cesarean
delivery without stratifying data for mode of delivery.
Inclusion of data of cesarean delivery only from these
RCTs could modify our findings. Finally, there was
high variability of study implementation such as
timing of antibiotics, placental removal technique,
diagnosis of endometritis, and socioeconomic status of
enrolled women. These variables could have affected
our findings. The inclusion of a study with metroni-
dazole may be a confounder, because metronidazole
is an antibiotic instead of an antiseptic preparation.
Our data concur with a prior Cochrane review.6
Haas et al pooled data from only five RCTs (1,766
women) evaluating the effects of vaginal cleansing
with povidone–iodine on postcesarean infectious
morbidity. They showed with a low quality of evi-
dence that vaginal preparation with povidone–iodine
immediately before cesarean delivery may reduce the
risk of postoperative endometritis. However, there
remains a lack of widespread uptake and previously
published guidelines on vaginal preparation have not
been modified to include cesarean delivery. More-
over, several more trials have been published after the
Cochrane review was completed.20–26
The concept of vaginal cleansing is not new to the
field of obstetrics and gynecology. Since the 1970s it
has been demonstrated that a povidone–iodine vagi-
nal scrub before vaginal surgery or abdominal hys-
terectomy is associated with lower postoperative
infectious morbidity.26 Prior studies showed that
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vaginal cleansing decreased the number of vaginal
bacterial species by 98%,27 especially Enterococcus
species.28 By cleansing the vagina before cesarean
delivery, there may be less bacterial load in the vagina
that might cause postoperative endometritis. In terms
of costs, vaginal cleansing with either povidone–
iodine or chlorhexidine is a low-cost intervention,
approximately $1.7 per 113-g bottle of chlorhexidine
and $1.4 per 118-mL surgical scrub with povidone–
iodine.29
In summary, vaginal cleansing immediately before
cesarean delivery in women in labor and in women with
ruptured membranes reduces the risk of postoperative
endometritis. Because it is generally an inexpensive and
simple intervention, we recommend preoperative vagi-
nal preparation in these women before cesarean delivery
with a sponge stick preparation of povidone–iodine 10%
for at least 30 seconds. More data are needed to assess
whether this intervention may be also useful before
cesarean delivery in women not in labor and for those
without ruptured membranes.
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